EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

AVRIL / BPIFRANCE / BPT ISRAEL / EVERTREE

M.8007

AVRIL / BPIFRANCE / BPT ISRAEL / EVERTREEAVRIL / BPT ISRAEL / EVERTREE JV
May 29, 2016
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

1.On April 28th 2016, the European Commission received a project of concentration in accordance with Article 4 of Regulation EC n°139/2004 of the Council, by which SPI – Sociétés de Projets Industriels, would acquire an equity interest in Avril Protein Solutions through which it would hold joint control over Evertree, a full-function joint-venture set up between Avril Protein Solutions, currently a subsidiary of the Avril Group, and Biopolymer Technologies Ltd.

2.Evertree is dedicated to the research and development and the manufacturing and marketing of products and solutions derived from vegetable proteins (oilseed meals) in applications such as additives in the resins used for the manufacture of wood composite boards and more generally in wood adhesives and in any relevant application that could be further developed.

The parties involved in the contemplated transaction are the following:

-- Avril Group, a French based group involved in human food, animal feed, biofuel and biochemical with a well-known experience in the production, extraction, valorization, marketing and sales of vegetable oils and proteins;

-- SPI – Société de Projets Industriels, an investment fund managed by Bpifrance Investissement, a management company authorized to operate (“agréée”) by the Autorité des marchés financiers, the French financial market regulator. SPI’s purpose is to invest in key industrial projects in France.

-- Biopolymer Technologies Ltd., an Israel-based R&D and IP startup having developed and tested a broad range of intellectual property related to the use of protein in applications such as but not limited to wood composite boards and polyurethane foams.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.

EUC

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia